Purity 98%: Dactinomycin with purity 98% is used in pediatric oncology treatment protocols, where it provides consistent cytotoxic efficacy against Wilms' tumor.

Molecular Weight 1255.4 g/mol: Dactinomycin with a molecular weight of 1255.4 g/mol is used in intravenous administration for rhabdomyosarcoma, where it ensures predictable pharmacokinetic behavior.

Stability Temperature 2–8°C: Dactinomycin with stability temperature of 2–8°C is used in hospital pharmacy storage, where it maintains long-term potency and reduces degradation risk.

pH 5–7: Dactinomycin with pH 5–7 is used in formulation of injectable chemotherapy agents, where it minimizes induction of local tissue irritation upon administration.

Solubility in Water 1 mg/mL: Dactinomycin with solubility in water of 1 mg/mL is used in preparation of infusion solutions, where it enables accurate and safe dosing adjustment for patients.

Sterility: Dactinomycin with sterility is used in aseptic production environments, where it ensures patient safety by preventing microbial contamination during cancer treatment.

Endotoxin Level <0.5 EU/mg: Dactinomycin with endotoxin level less than 0.5 EU/mg is used for manufacturing clinical-grade vials, where it reduces the risk of pyrogenic reactions in immunocompromised patients.

Particle Size <5 µm: Dactinomycin with particle size less than 5 µm is used in injectable suspensions, where it achieves uniform dispersion and enhances bioavailability.

Residual Solvent <0.1%: Dactinomycin with residual solvent less than 0.1% is used in final drug product release, where it meets regulatory standards and ensures patient safety.

UV Absorbance 442 nm: Dactinomycin with UV absorbance at 442 nm is used in quality control processes, where it enables precise quantification for batch validation.